Clinical Trial Update: Liraglutide Use in Prader-Willi Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating liraglutide for Prader-Willi syndrome (with Type 2 diabetes mellitus) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome
• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Vancouver General Hospital | Conditions: Diabetes Mellitus Type 2, Prader Willi Syndrome | Phase 4 | Status: TERMINATED